Fresenius | FRE - Des Atouts

Prix De L'Action
40.25
Variation Quotidienne
-0.46 -1.13%
Mensuellement
-9.57%
Annuel
1.00%
Q2 Prévisions
39.19




Des Atouts Changement Date
Akzo Nobel EUR 15.49B 1.53B 2026-03
Alcon AG USD 31.56B 31M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
BASF EUR 76.17B 267M 2025-12
Bayer EUR 104.54B 331M 2025-12
Beiersdorf EUR 12.76B 166M 2025-12
DaVita Healthcare Partners USD 17.48B 75.79M 2025-12
Demant DKK 39.07B 6.43B 2025-12
E.ON EUR 110.68B 3.65B 2025-12
Essilor EUR 63.9B 1.97B 2025-12
Fresenius EUR 42.46B 1.14B 2025-09
Fresenius Medical Care EUR 31B 115.33M 2025-12
Getinge SEK 63.92B 4.3B 2024-12
Givaudan CHF 11.86B 587M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
GN Store Nord DKK 29.23B 170M 2025-12
GRIFOLS EUR 19.71B 141.77M 2025-12
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lonza CHF 18.97B 164M 2025-12
Merck EUR 51.53B 600M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Philips EUR 26.94B 605M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
RWE EUR 101.72B 5.51B 2025-12
Sanofi EUR 128.02B 1.22B 2026-03
Smith & Nephew USD 10.69B 150M 2025-12